Mobile

Multicenter, open-label, randomized study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in healthy y...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-009177-10

Multicenter, open-label, randomized study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in healthy young female volunteers over a period of 3 treatment cycles

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to evaluate the inhibition of ovulation in treatment cycles 2 and 3 administration of two different patches containing ethinylestradiol (EE) / gestodene (GSD) for 3 treatment cycles

Critère d'inclusion

  • The trial will be performed in healthy female volunteers. The intended indication is femal contraception

Liens